Eone Diagnomics Genome Center Future Growth
Future criteria checks 0/6
We currently don't have sufficient analyst coverage to forecast growth and revenue for Eone Diagnomics Genome Center.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
| Life Sciences earnings growth | 27.1% |
| Revenue growth rate | n/a |
| Future return on equity | n/a |
| Analyst coverage | None |
| Last updated | n/a |
Recent future growth updates
No updates
Recent updates
There's No Escaping Eone Diagnomics Genome Center Co., Ltd.'s (KOSDAQ:245620) Muted Revenues Despite A 43% Share Price Rise
Feb 29
Is Eone Diagnomics Genome Center (KOSDAQ:245620) Weighed On By Its Debt Load?
Apr 06If You Had Bought Eone Diagnomics Genome Center (KOSDAQ:245620) Shares A Year Ago You'd Have Earned 54% Returns
Feb 24Do Insiders Own Lots Of Shares In Eone Diagnomics Genome Center Co., Ltd. (KOSDAQ:245620)?
Jan 20Eone Diagnomics Genome Center (KOSDAQ:245620) Is Carrying A Fair Bit Of Debt
Dec 16In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Eone Diagnomics Genome Center has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 3/31/2024 | 73,966 | -39,884 | -9,649 | -10,923 | N/A |
| 12/31/2023 | 88,457 | -33,027 | -14,692 | -14,025 | N/A |
| 9/30/2023 | 100,554 | -30,791 | -14,766 | -6,531 | N/A |
| 6/30/2023 | 99,636 | -37,705 | -26,015 | -7,177 | N/A |
| 3/31/2023 | 96,173 | -24,102 | -34,343 | 2,467 | N/A |
| 12/31/2022 | 94,244 | -29,865 | -50,301 | -10,892 | N/A |
| 9/30/2022 | 91,964 | -39,728 | -50,104 | -14,271 | N/A |
| 6/30/2022 | 95,540 | -30,075 | -36,351 | -10,298 | N/A |
| 3/31/2022 | 90,842 | -22,796 | -27,886 | -17,812 | N/A |
| 12/31/2021 | 89,282 | -20,667 | -15,516 | -1,730 | N/A |
| 9/30/2021 | 91,354 | -9,238 | -17,699 | -1,097 | N/A |
| 6/30/2021 | 95,302 | -6,556 | -18,001 | -2,654 | N/A |
| 3/31/2021 | 99,049 | -11,570 | -12,080 | 839 | N/A |
| 12/31/2020 | 92,541 | -10,398 | -11,245 | -5,497 | N/A |
| 9/30/2020 | 80,840 | -4,399 | -12,312 | -4,737 | N/A |
| 6/30/2020 | 65,727 | -10,713 | -16,656 | -6,347 | N/A |
| 3/31/2020 | 59,647 | -10,518 | -16,864 | -8,089 | N/A |
| 12/31/2019 | 56,722 | -9,802 | -17,977 | -9,363 | N/A |
| 9/30/2019 | 55,273 | -8,765 | -16,771 | -11,715 | N/A |
| 6/30/2019 | 46,550 | -8,500 | -15,977 | -13,021 | N/A |
| 3/31/2019 | 30,772 | -8,207 | -11,980 | -8,157 | N/A |
| 12/31/2018 | 21,497 | -7,602 | -8,612 | -5,961 | N/A |
| 9/30/2018 | 8,953 | -7,113 | -8,531 | -6,650 | N/A |
| 6/30/2018 | 5,183 | -5,948 | -6,038 | -4,434 | N/A |
| 3/31/2018 | 4,827 | -5,692 | -5,756 | -4,492 | N/A |
| 12/31/2017 | 3,235 | -6,286 | N/A | -4,031 | N/A |
| 12/31/2016 | 1,393 | -3,867 | N/A | -3,342 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if A245620's forecast earnings growth is above the savings rate (2.5%).
Earnings vs Market: Insufficient data to determine if A245620's earnings are forecast to grow faster than the KR market
High Growth Earnings: Insufficient data to determine if A245620's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: Insufficient data to determine if A245620's revenue is forecast to grow faster than the KR market.
High Growth Revenue: Insufficient data to determine if A245620's revenue is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if A245620's Return on Equity is forecast to be high in 3 years time